TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 315.39%86.45M | ---- | 41.05%20.81M | ---- | 186.21%14.76M | ---- | 56.37%-17.12M | ---- | -351.31%-39.23M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -1,271.79%-535K | ---- | 31.58%-39K | ---- | -137.25%-57K | ---- | 225.53%153K | ---- | 111.87%47K |
Impairment and provisions: | ---- | -196.39%-1.74M | ---- | --1.8M | ---- | ---- | ---- | -27.95%2M | ---- | 1,047.44%2.78M |
-Other impairments and provisions | ---- | -196.39%-1.74M | ---- | --1.8M | ---- | ---- | ---- | -27.95%2M | ---- | 1,047.44%2.78M |
Revaluation surplus: | ---- | ---9.11M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---9.11M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | --16K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | --16K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 21.30%46.23M | ---- | -3.62%38.11M | ---- | 7.54%39.54M | ---- | 9.11%36.77M | ---- | -2.51%33.7M |
-Other depreciation and amortization | ---- | -66.73%1.44M | ---- | --4.33M | ---- | ---- | ---- | ---- | ---- | ---- |
Financial expense | ---- | 23.92%13.38M | ---- | -37.67%10.79M | ---- | 27.35%17.32M | ---- | -1.81%13.6M | ---- | -50.56%13.85M |
Special items | ---- | -1,584.69%-29.28M | ---- | 113.57%1.97M | ---- | -7,312.76%-14.53M | ---- | ---196K | ---- | ---- |
Operating profit before the change of operating capital | ---- | 43.51%105.41M | ---- | 28.80%73.45M | ---- | 61.98%57.03M | ---- | 215.95%35.21M | ---- | -84.72%11.14M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -1,048.81%-132.73M | ---- | -758.35%-11.55M | ---- | -9.63%1.76M | ---- | 202.49%1.94M | ---- | -93.92%642K |
Accounts receivable (increase)decrease | ---- | 145.14%11.97M | ---- | -578.75%-26.51M | ---- | 65.58%-3.91M | ---- | ---11.35M | ---- | ---- |
Accounts payable increase (decrease) | ---- | 1,525.97%425.88M | ---- | -225.60%-29.87M | ---- | -38.87%23.78M | ---- | 10.17%38.9M | ---- | 165.53%35.31M |
prepayments (increase)decrease | ---- | -2,337.74%-109.28M | ---- | -127.68%-4.48M | ---- | -241.15%-1.97M | ---- | -51.44%1.4M | ---- | -55.33%2.87M |
Cash from business operations | ---- | 28,699.24%301.24M | ---- | -98.64%1.05M | ---- | 16.02%76.69M | ---- | 32.29%66.1M | ---- | 38.63%49.97M |
Other taxs | ---- | ---34.22M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - operating | ---- | ---615K | ---- | ---- | ---- | 97.78%-1K | ---- | 55.45%-45K | ---- | ---101K |
Special items of business | 1,149.79%121.92M | ---- | 3,148.44%9.76M | ---- | -100.92%-320K | ---- | 191.43%34.78M | ---- | -66.01%11.94M | ---- |
Net cash from operations | 1,149.79%121.92M | 25,369.41%266.41M | 3,148.44%9.76M | -98.64%1.05M | -100.92%-320K | 16.10%76.69M | 191.43%34.78M | 32.46%66.05M | -66.01%11.94M | 38.35%49.87M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 1,271.79%535K | ---- | -31.58%39K | ---- | 307.14%57K | ---- | -70.83%14K | ---- | --48K |
Decrease in deposits (increase) | ---- | ---- | ---- | ---20M | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | --11K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | ---- | -1,234.48%-175.06M | ---- | 66.92%-13.12M | ---- | 4.64%-39.66M | ---- | 29.85%-41.59M | ---- | 48.03%-59.28M |
Selling intangible assets | ---- | ---- | ---- | 939.72%13.3M | ---- | --1.28M | ---- | ---- | ---- | ---- |
Purchase of intangible assets | ---- | 56.84%-1.43M | ---- | 74.92%-3.3M | ---- | -188.40%-13.17M | ---- | -454.37%-4.57M | ---- | -14.44%-824K |
Cash on investment | ---- | ---10.91M | ---- | ---- | ---- | ---- | ---- | 93.33%-57K | ---- | ---855K |
Other items in the investment business | 77.80%-49M | ---- | ---220.75M | 41.25%-4.06M | ---- | ---6.91M | -74.62%-35.37M | ---- | 59.52%-20.25M | ---- |
Net cash from investment operations | 77.80%-49M | -588.39%-186.84M | ---220.75M | 53.53%-27.14M | ---- | -26.41%-58.4M | -74.62%-35.37M | 24.15%-46.2M | 59.52%-20.25M | 48.71%-60.91M |
Net cash before financing | 134.56%72.92M | 404.90%79.57M | -65,836.88%-211M | -242.71%-26.1M | 45.21%-320K | -7.90%18.29M | 92.98%-584K | 279.75%19.86M | 44.25%-8.32M | 86.65%-11.05M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 49.46%161.7M | ---- | 213.64%108.19M | ---- | -34.37%34.49M | ---- | 34.38%52.56M | ---- | -58.84%39.11M |
Refund | ---- | -23.38%-227.04M | ---- | -246.39%-184.03M | ---- | -9.07%-53.13M | ---- | -86.74%-48.71M | ---- | 31.45%-26.08M |
Issuing shares | ---- | -86.64%21M | ---- | --157.16M | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | -2,773.68%-34.71M | ---- | 93.95%-1.21M | ---- | -1,558.97%-19.97M | ---- | 0.00%-1.2M |
Other items of the financing business | -113.27%-24.72M | ---- | 285.75%186.33M | ---- | 931.48%48.3M | ---- | -68.33%4.68M | ---- | 13.11%14.79M | ---- |
Net cash from financing operations | -113.27%-24.72M | -195.96%-44.73M | 285.75%186.33M | 334.05%46.61M | 931.48%48.3M | -19.42%-19.92M | -68.33%4.68M | -247.80%-16.68M | 13.11%14.79M | -79.77%11.28M |
Effect of rate | -1,842.95%-27.28M | -3,670.44%-11.99M | 69.90%-1.4M | -302.55%-318K | -7,503.17%-4.66M | -73.66%157K | -89.81%63K | 304.11%596K | 20.00%618K | -104.31%-292K |
Other items affecting net cash | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net Cash | 295.39%48.19M | 69.82%34.84M | -151.40%-24.67M | 1,359.36%20.52M | 1,070.63%47.98M | -151.24%-1.63M | -36.66%4.1M | 1,241.35%3.18M | 450.92%6.47M | 100.88%237K |
Begining period cash | 6.38%47.49M | 454.48%24.64M | 904.52%44.64M | -24.88%4.44M | -24.88%4.44M | 176.32%5.92M | 176.32%5.92M | -2.50%2.14M | -2.50%2.14M | -90.19%2.2M |
Cash at the end | 268.31%68.4M | 92.72%47.49M | -61.12%18.57M | 454.48%24.64M | 373.94%47.76M | -24.88%4.44M | 9.19%10.08M | 176.32%5.92M | 964.59%9.23M | -2.50%2.14M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Chang Ying (Hong Kong) Certified Public Accountants Limited | -- | Chang Ying (Hong Kong) Certified Public Accountants Limited | -- | Chang Ying (Hong Kong) Certified Public Accountants Limited | -- | Chang Ying (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.